Investing.com -- UBS upgraded TransDigm Group Inc, now rated "Buy" from "Neutral," on stabilised aftermarket growth, margin expansion, and increased capital deployment.
The bank forecasts aftermarket growth between 10 and 11%, easing concerns of further deceleration. It also projects EBITDA margins to expand by 100 basis points per year, above consensus estimates of 40-60 basis points, while still conservative compared to historical trends.
“TransDigm is a compounder of earnings organically and inorganically, with a recurring and often sole-source business model. A more M&A friendly environment could be further upside to our numbers,” analyst said.
UBS noted that TransDigm's net leverage of 5X, within its 5-7X target range, could result in $12 billion in available capital by year-end and $24 billion by fiscal 2027.
The price target was raised to $1,595 from $1,502, reflecting higher EBITDA assumptions and a revised 21.0X 5-8 quarter EV/EBITDA multiple.
“We expect aftermarket growth to stabilize and accelerate from F1Q, with above-consensus margin expansion and the potential for a step-up in capital deployment,” analyst at UBS said.
Related Articles
UBS upgrades TransDigm on margin expansion, capital deployment
Bank of England policymakers at odds over pace of interest rate cuts
Palliser asks Rio Tinto to seek Australian shareholder vote on dual listing
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。